CareDx (CDNA) Liabilities and Shareholders Equity (2013 - 2026)

CareDx has disclosed Liabilities and Shareholders Equity across 14 years of filings, most recently posting $533.0 million for Q2 2026.

• In Q2 2026, Liabilities and Shareholders Equity rose 19.97% year-over-year to $533.0 million; the TTM figure through Jun 2026 stood at $1.8 billion (down 5.91% YoY), while the FY2025 annual figure was $413.2 million, down 15.85% from the prior year.
• Liabilities and Shareholders Equity came in at $533.0 million for Q2 2026 at CareDx, up from $411.1 million in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $546.7 million in Q1 2022 to a low of $411.1 million in Q1 2026.
• Average Liabilities and Shareholders Equity over 5 years is $488.7 million, with a median of $490.3 million recorded in 2024.
• The largest YoY upside for Liabilities and Shareholders Equity was 19.97% in 2026 against a maximum downside of 16.05% in 2026.
• Over 5 years, Liabilities and Shareholders Equity stood at $543.0 million in 2022, then dropped by 14.03% to $466.8 million in 2023, then climbed by 5.19% to $491.0 million in 2024, then slipped by 15.85% to $413.2 million in 2025, then rose by 28.98% to $533.0 million in 2026.
• Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $533.0 million in Q2 2026, $411.1 million in Q1 2026, and $413.2 million in Q4 2025.